TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive Basic Biology Progress, Improved Survival Since 1971 Described By DeVita At Senate Hearing February 27, 1981